We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Poniard Pharmaceuticals Licenses Kinase Inhibitors from the Scripps Research Institute

News   May 15, 2008

 
Poniard Pharmaceuticals Licenses Kinase Inhibitors from the Scripps Research Institute
 
 
 

RELATED ARTICLES

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

Chemists Synthesize > 1 Million Macrocycles for Drug Discovery

News

Chemists from the University of Basel have built a rich collection of natural product-like macrocycles that can be mined for new medicines as the researchers.

READ MORE

Synthesized Scorpion Venom Compounds Could Help Battle Bacterial Infections

News

A scorpion native to Eastern Mexico may have more than just toxin in its sting. Researchers at Stanford University and in Mexico have found that the venom also contains two color-changing compounds that could help fight bacterial infections.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE